Alfredo Matías Rodríguez Granillo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alfredo Matías Rodríguez Granillo has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Alfredo E. Rodriguez
Division of Cardiology, Otamendi Hospital, Buenos Aires 1001, Argentina
6 shared publications - Ricardo Pérez de la Hoz
Division Cardiologia. Hospital de Clinicas José de San Martín. UBA. Ciudad Autónoma de Buenos Aires, Argentina
4 shared publications Camila Correa Sadouet
3 shared publicationsHernán Jensen
3 shared publicationsJorge De All
3 shared publications- Juan Mieres
Servicio de Cardiología Intervencionista, Sanatorio Las lomas, Buenos Aires, Argentina
3 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
Disección Coronaria Espontánea: ¿Qué hemos aprendido y hacia dónde vamos?
Spontaneous coronary artery dissection (SCAD) is a trigger for acute myocardial infarction (AMI), mainly in young or perimenopausal women with minimal or no cardiovascular risk factors. Diagnosis is complex. In 2022, the first multicenter registry of SCAD with long-term follow-up was published, but there are no documents or consensus statements based on real-world data in Latin America. Therefore, there is an urgent need to conduct an in-depth review of the literature to begin generating findings that can explain the behavior of the disease. This review addresses these objectives.
- 30 June 2026
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
Open AccessDisección Coronaria Espontánea: ¿Qué hemos aprendido y hacia dónde vamos?
Spontaneous coronary artery dissection (SCAD) is a trigger for acute myocardial infarction (AMI), mainly in young or perimenopausal women with minimal or no cardiovascular risk factors. Diagnosis is complex. In 2022, the first multicenter registry of SCAD with long-term follow-up was published, but there are no documents or consensus statements based on real-world data in Latin America. Therefore, there is an urgent need to conduct an in-depth review of the literature to begin generating findings that can explain the behavior of the disease. This review addresses these objectives.
- Open Access
- 3 February 2026
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
Registro piloto multicéntrico de disección coronaria espontánea en Argentina
Introducción: La disección coronaria espontánea (DCE) es una causa relevante de infarto agudo de miocardio en adultos jóvenes, en especial en mujeres de mediana edad sin factores de riesgo cardiovascular tradicionales. Debido a su baja incidencia y a la escasa información disponible en nuestro medio, se desarrolló un registro multicéntrico con el fin de describir las características clínicas y la evolución de pacientes con esta patología. Objetivos: Describir las características clínicas, las estrategias terapéuticas y los resultados a mediano y largo plazo de pacientes con DCE en nuestro país, donde la enfermedad no había sido caracterizada previamente de manera sistemática. Material y métodos: Estudio observacional, prospectivo y multicéntrico realizado en cuatro centros médicos privados y dos hospitales universitarios. Entre enero de 2023 y enero de 2025 se incluyeron 26 pacientes con diagnóstico de DCE confirmado por angiografía coronaria. Se analizaron variables demográficas, factores de riesgo cardiovascular, factores desencadenantes, estresores psicosociales y físicos, comorbilidades, datos de laboratorio, características angiográficas, tipo de tratamiento, resolución, recurrencia y evolución clínica hasta un año posterior al alta. Resultados: Se analizaron 26 pacientes, de los cuales 84,6 % fueron mujeres, con una mediana de edad de 47 años. La hipertensión arterial fue el factor de riesgo más frecuente. El estrés físico o emocional se reconoció como desencadenante en la mayoría de los pacientes. Todos se presentaron como síndrome coronario agudo, predominando el sin elevación del segmento ST. La arteria descendente anterior fue la más comprometida y el patrón angiográfico más frecuente fue la disección tipo 2A. Conclusión: La DCE afecta principalmente a mujeres jóvenes y suele manifestarse como síndrome coronario agudo sin elevación del ST, con el estrés como principal desencadenante. En este registro piloto nacional, las características clínicas, angiográficas y terapéuticas observadas fueron concordantes con las reportadas en series internacionales, a nivel local actual.
- 3 February 2026
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
Open AccessRegistro piloto multicéntrico de disección coronaria espontánea en Argentina
Introducción: La disección coronaria espontánea (DCE) es una causa relevante de infarto agudo de miocardio en adultos jóvenes, en especial en mujeres de mediana edad sin factores de riesgo cardiovascular tradicionales. Debido a su baja incidencia y a la escasa información disponible en nuestro medio, se desarrolló un registro multicéntrico con el fin de describir las características clínicas y la evolución de pacientes con esta patología. Objetivos: Describir las características clínicas, las estrategias terapéuticas y los resultados a mediano y largo plazo de pacientes con DCE en nuestro país, donde la enfermedad no había sido caracterizada previamente de manera sistemática. Material y métodos: Estudio observacional, prospectivo y multicéntrico realizado en cuatro centros médicos privados y dos hospitales universitarios. Entre enero de 2023 y enero de 2025 se incluyeron 26 pacientes con diagnóstico de DCE confirmado por angiografía coronaria. Se analizaron variables demográficas, factores de riesgo cardiovascular, factores desencadenantes, estresores psicosociales y físicos, comorbilidades, datos de laboratorio, características angiográficas, tipo de tratamiento, resolución, recurrencia y evolución clínica hasta un año posterior al alta. Resultados: Se analizaron 26 pacientes, de los cuales 84,6 % fueron mujeres, con una mediana de edad de 47 años. La hipertensión arterial fue el factor de riesgo más frecuente. El estrés físico o emocional se reconoció como desencadenante en la mayoría de los pacientes. Todos se presentaron como síndrome coronario agudo, predominando el sin elevación del segmento ST. La arteria descendente anterior fue la más comprometida y el patrón angiográfico más frecuente fue la disección tipo 2A. Conclusión: La DCE afecta principalmente a mujeres jóvenes y suele manifestarse como síndrome coronario agudo sin elevación del ST, con el estrés como principal desencadenante. En este registro piloto nacional, las características clínicas, angiográficas y terapéuticas observadas fueron concordantes con las reportadas en series internacionales, a nivel local actual.
- Open Access
- 22 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 2871
Randomized Clinical Trial Comparing Bare-Metal Stents Plus Colchicine Versus Drug-Eluting Stents for Preventing Adverse Cardiac Outcomes: Three-Year Follow-Up Results of the ORal Colchicine in Argentina (ORCA) Trial
Background: In patients with coronary artery disease, bare-metal stents (BMS) are considered a safer but less effective treatment than drug-eluting stents (DES). Oral colchicine therapy may compensate for this limitation of BMS. This randomized trial compared the cost-effectiveness of two different revascularization strategies during percutaneous coronary intervention (PCI). Methods: Between March 2020 and April 2022, 410 patients were randomly treated with PCI with BMS plus colchicine (BMS-CO: 205 patients) or DES (205 patients) The patients in the BMS-CO group received 0.5 mg oral doses of colchicine for 3 months. The primary endpoint was major adverse cardiac and cerebrovascular events (MACEs), defined as the composite of death, myocardial infarction, stroke, or target vessel revascularization (TVR), and the costs of each treatment strategy. The secondary endpoints included the individual components of MACEs. Results: No significant differences were observed in baseline characteristics, and 76% of the patients presented with acute coronary syndromes. The median follow-up period was 36.8 months. Five percent of the patients in the BMS-CO group discontinued study medication. The cumulative incidence of MACEs was not significantly different, with 12.7% in the BMS-CO group and 15.6% in the DES2G group (p = 0.39) as well individual components of the clinical endpoint. The cumulative costs were lower in the BMS-CO group than in the DES2G group (USD 4826.4 ± 2512 vs. USD 5708 ± 3637, p < 0.001). Conclusions: In the 3 years, the DES strategy failed to be cost-saving compared to BMS-CO. However, due to the small sample size, the equivalence in clinical outcomes with both strategies can occur by chance (NCT04382443).
- 22 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 2871
Open AccessRandomized Clinical Trial Comparing Bare-Metal Stents Plus Colchicine Versus Drug-Eluting Stents for Preventing Adverse Cardiac Outcomes: Three-Year Follow-Up Results of the ORal Colchicine in Argentina (ORCA) Trial
Background: In patients with coronary artery disease, bare-metal stents (BMS) are considered a safer but less effective treatment than drug-eluting stents (DES). Oral colchicine therapy may compensate for this limitation of BMS. This randomized trial compared the cost-effectiveness of two different revascularization strategies during percutaneous coronary intervention (PCI). Methods: Between March 2020 and April 2022, 410 patients were randomly treated with PCI with BMS plus colchicine (BMS-CO: 205 patients) or DES (205 patients) The patients in the BMS-CO group received 0.5 mg oral doses of colchicine for 3 months. The primary endpoint was major adverse cardiac and cerebrovascular events (MACEs), defined as the composite of death, myocardial infarction, stroke, or target vessel revascularization (TVR), and the costs of each treatment strategy. The secondary endpoints included the individual components of MACEs. Results: No significant differences were observed in baseline characteristics, and 76% of the patients presented with acute coronary syndromes. The median follow-up period was 36.8 months. Five percent of the patients in the BMS-CO group discontinued study medication. The cumulative incidence of MACEs was not significantly different, with 12.7% in the BMS-CO group and 15.6% in the DES2G group (p = 0.39) as well individual components of the clinical endpoint. The cumulative costs were lower in the BMS-CO group than in the DES2G group (USD 4826.4 ± 2512 vs. USD 5708 ± 3637, p < 0.001). Conclusions: In the 3 years, the DES strategy failed to be cost-saving compared to BMS-CO. However, due to the small sample size, the equivalence in clinical outcomes with both strategies can occur by chance (NCT04382443).
- Open Access
- 26 October 2023
- Published by Revista Argentina de Cardiologia
- Vol. 91 (5) , 359-364
Estado inflamatorio en el infarto agudo de miocardio, su impacto en el remodelado ventricular y nuevas dianas terapéuticas
La cardiopatía isquémica es la causa más frecuente de insuficiencia cardíaca, con una alta incidencia de esta a pesar de la revascularización precoz y la modulación neurohormonal.En el contexto del infarto agudo de miocardio los cardiomiocitos necrosados inducen la activación del sistema inmune innato, con aumento de la concentración de células inflamatorias que ayudan a eliminar las células muertas, e iniciar una respuesta correctiva que permite la formación adecuada de tejido cicatrizal.La prolongación o expansión de la respuesta inflamatoria posterior al infarto contribuye al remodelado adverso ventricular y al desarrollo de insuficiencia cardíaca.Entender los mecanismos inflamatorios que se desarrollan producto del infarto, y su impacto en el remodelado adverso que aumenta el número de eventos cardiovasculares mayores, permite comprender a la inflamación como un objetivo terapéutico. Palabras clave: Infarto agudo de miocardio - Inflamación - Remodelado ventricular Cómo citar este artículo: Moreno A, Rodríguez Granillo AM, Pérez de la Hoz R. Estado inflamatorio en el infarto agudo de miocardio, su impacto en el remodelado ventricular y nuevas dianas terapéuticas. Rev Argent Cardiol 2023;91:359-64. http://dx.doi.org/10.7775/rac.es.v91.i5.20669 Ischemic heart disease is the most common cause of heart failure, with a high incidence of heart failure despite early revas cularization and neurohormonal modulation. In the acute myocardial infarction setting, necrotized cardiomyocytes induce activation of the innate immune system, increasing the levels of inflammatory cells to help remove dead cells and initiate a corrective response, which allows for proper scar tissue formation. A prolonged or expanded inflammatory response after infarction contributes to adverse ventricular remodeling and develop ment of heart failure. Understanding the inflammatory mechanisms that emerge as a result of myocardial infarction and their impact on adverse remodeling that leads to an increased number of major adverse cardiovascular events makes it possible to understand inflam mation as a therapy target. Key words: Acute Myocardial Infarction - Inflammation - Ventricular Remodeling How to cite this article Moreno A, Rodríguez Granillo AM, Pérez de ña Hoz R. Inflammation in Acute Myocardial Infarction, Impact on Ventricular Remodeling, and New Therapeutic Targets. Rev Argent Cardiol 2023;91:343-8. http://dx.doi.org/10.7775/rac.v91.i5.20669
- 26 October 2023
- Published by Revista Argentina de Cardiologia
- Vol. 91 (5) , 359-364
Open AccessEstado inflamatorio en el infarto agudo de miocardio, su impacto en el remodelado ventricular y nuevas dianas terapéuticas
La cardiopatía isquémica es la causa más frecuente de insuficiencia cardíaca, con una alta incidencia de esta a pesar de la revascularización precoz y la modulación neurohormonal.En el contexto del infarto agudo de miocardio los cardiomiocitos necrosados inducen la activación del sistema inmune innato, con aumento de la concentración de células inflamatorias que ayudan a eliminar las células muertas, e iniciar una respuesta correctiva que permite la formación adecuada de tejido cicatrizal.La prolongación o expansión de la respuesta inflamatoria posterior al infarto contribuye al remodelado adverso ventricular y al desarrollo de insuficiencia cardíaca.Entender los mecanismos inflamatorios que se desarrollan producto del infarto, y su impacto en el remodelado adverso que aumenta el número de eventos cardiovasculares mayores, permite comprender a la inflamación como un objetivo terapéutico. Palabras clave: Infarto agudo de miocardio - Inflamación - Remodelado ventricular Cómo citar este artículo: Moreno A, Rodríguez Granillo AM, Pérez de la Hoz R. Estado inflamatorio en el infarto agudo de miocardio, su impacto en el remodelado ventricular y nuevas dianas terapéuticas. Rev Argent Cardiol 2023;91:359-64. http://dx.doi.org/10.7775/rac.es.v91.i5.20669 Ischemic heart disease is the most common cause of heart failure, with a high incidence of heart failure despite early revas cularization and neurohormonal modulation. In the acute myocardial infarction setting, necrotized cardiomyocytes induce activation of the innate immune system, increasing the levels of inflammatory cells to help remove dead cells and initiate a corrective response, which allows for proper scar tissue formation. A prolonged or expanded inflammatory response after infarction contributes to adverse ventricular remodeling and develop ment of heart failure. Understanding the inflammatory mechanisms that emerge as a result of myocardial infarction and their impact on adverse remodeling that leads to an increased number of major adverse cardiovascular events makes it possible to understand inflam mation as a therapy target. Key words: Acute Myocardial Infarction - Inflammation - Ventricular Remodeling How to cite this article Moreno A, Rodríguez Granillo AM, Pérez de ña Hoz R. Inflammation in Acute Myocardial Infarction, Impact on Ventricular Remodeling, and New Therapeutic Targets. Rev Argent Cardiol 2023;91:343-8. http://dx.doi.org/10.7775/rac.v91.i5.20669
- 24 July 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (14) , 1820
Adjudicating Causes of Death in Revascularization Randomized Clinical Trials
- 24 July 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (14) , 1820
Adjudicating Causes of Death in Revascularization Randomized Clinical Trials
- Open Access
- 14 June 2023
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
Resultados de un registro prospectivo de pacientes con desórdenes hipertensivos del embarazo en un centro de la Ciudad de Buenos Aires
Background: Hypertensive disorders of pregnancy (HDP) complicate 10% of pregnancies. They are the main cause of maternal mortality and require a multidisciplinary team to address them.Objectives: The aim of this study was to quantify the prevalence and define the characteristics and outcome of HDP in a center with a program focused on its management.Methods: This was a continuous and prospective registry from November 2019 to July 2021 that included all patients with HDP [chronic hypertension (CHT), gestational hypertension (GHT), early-onset preeclampsia (EPE), late preeclampsia (LPE),superimposed preeclampsia (SIPE) and eclampsia] who met the inclusion criteria. Patients without medical coverage that prevented long-term outpatient follow-up at the institution were excluded. Baseline characteristics and evolution, treatment and persistent HT after puerperium were evaluated. The incidence of intrauterine growth retardation (IUGR), pretermdelivery, maternal mortality and neonatal death within the first 28 days of life was analyzed.Results: Among a total f 5825 deliveries/caesarean sections, 152 patients with GHT (37.5%), EPE (19.7%), LPE (38.8%), SIPE (3.3%), and eclampsia (0.6%) who met the inclusion criteria were included in the study. Mean age was 36.4±5.6 years. Aspirin was administered to 38.1% of patients. The most commonly used antihypertensive drugs were labetalol (65.8%) andenalapril (44.1%) during pregnancy and puerperium, respectively. There was no maternal mortality, and neonatal mortality was 3.6%. Persistent HT was 20.0%.Conclusion: Late preeclampsia was the most frequent HDP in the population analyzed. More than half of the patients who developed HDP did not receive preventive treatment with aspirin, showing a deficit in the identification of the population at risk. One in 5 HDP patients remained with CHTN after puerperium. How to cite this article: Correa Sadouet C, Rodríguez Granillo AM, Jensen H, Pérez de la Hoz R, Vetulli H, De All J, et al. Results of a Prospective Registry of Patients with Hypertensive Disorders of Pregnancy in a Center of the City of Buenos Aires. Rev Argent Cardiol 2022;90:124-9. http://dx.doi.org/10.7775/rac.v90.i2.20505
- 14 June 2023
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
Open AccessResultados de un registro prospectivo de pacientes con desórdenes hipertensivos del embarazo en un centro de la Ciudad de Buenos Aires
Background: Hypertensive disorders of pregnancy (HDP) complicate 10% of pregnancies. They are the main cause of maternal mortality and require a multidisciplinary team to address them.Objectives: The aim of this study was to quantify the prevalence and define the characteristics and outcome of HDP in a center with a program focused on its management.Methods: This was a continuous and prospective registry from November 2019 to July 2021 that included all patients with HDP [chronic hypertension (CHT), gestational hypertension (GHT), early-onset preeclampsia (EPE), late preeclampsia (LPE),superimposed preeclampsia (SIPE) and eclampsia] who met the inclusion criteria. Patients without medical coverage that prevented long-term outpatient follow-up at the institution were excluded. Baseline characteristics and evolution, treatment and persistent HT after puerperium were evaluated. The incidence of intrauterine growth retardation (IUGR), pretermdelivery, maternal mortality and neonatal death within the first 28 days of life was analyzed.Results: Among a total f 5825 deliveries/caesarean sections, 152 patients with GHT (37.5%), EPE (19.7%), LPE (38.8%), SIPE (3.3%), and eclampsia (0.6%) who met the inclusion criteria were included in the study. Mean age was 36.4±5.6 years. Aspirin was administered to 38.1% of patients. The most commonly used antihypertensive drugs were labetalol (65.8%) andenalapril (44.1%) during pregnancy and puerperium, respectively. There was no maternal mortality, and neonatal mortality was 3.6%. Persistent HT was 20.0%.Conclusion: Late preeclampsia was the most frequent HDP in the population analyzed. More than half of the patients who developed HDP did not receive preventive treatment with aspirin, showing a deficit in the identification of the population at risk. One in 5 HDP patients remained with CHTN after puerperium. How to cite this article: Correa Sadouet C, Rodríguez Granillo AM, Jensen H, Pérez de la Hoz R, Vetulli H, De All J, et al. Results of a Prospective Registry of Patients with Hypertensive Disorders of Pregnancy in a Center of the City of Buenos Aires. Rev Argent Cardiol 2022;90:124-9. http://dx.doi.org/10.7775/rac.v90.i2.20505
- Open Access
- 14 June 2023
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
Resultados de un registro prospectivo de pacientes con desórdenes hipertensivos del embarazo en un centro de la Ciudad de Buenos Aires
Background: Hypertensive disorders of pregnancy (HDP) complicate 10% of pregnancies. They are the main cause of maternal mortality and require a multidisciplinary team to address them.Objectives: The aim of this study was to quantify the prevalence and define the characteristics and outcome of HDP in a center with a program focused on its management.Methods: This was a continuous and prospective registry from November 2019 to July 2021 that included all patients with HDP [chronic hypertension (CHT), gestational hypertension (GHT), early-onset preeclampsia (EPE), late preeclampsia (LPE),superimposed preeclampsia (SIPE) and eclampsia] who met the inclusion criteria. Patients without medical coverage that prevented long-term outpatient follow-up at the institution were excluded. Baseline characteristics and evolution, treatment and persistent HT after puerperium were evaluated. The incidence of intrauterine growth retardation (IUGR), pretermdelivery, maternal mortality and neonatal death within the first 28 days of life was analyzed.Results: Among a total f 5825 deliveries/caesarean sections, 152 patients with GHT (37.5%), EPE (19.7%), LPE (38.8%), SIPE (3.3%), and eclampsia (0.6%) who met the inclusion criteria were included in the study. Mean age was 36.4±5.6 years. Aspirin was administered to 38.1% of patients. The most commonly used antihypertensive drugs were labetalol (65.8%) andenalapril (44.1%) during pregnancy and puerperium, respectively. There was no maternal mortality, and neonatal mortality was 3.6%. Persistent HT was 20.0%.Conclusion: Late preeclampsia was the most frequent HDP in the population analyzed. More than half of the patients who developed HDP did not receive preventive treatment with aspirin, showing a deficit in the identification of the population at risk. One in 5 HDP patients remained with CHTN after puerperium. How to cite this article: Correa Sadouet C, Rodríguez Granillo AM, Jensen H, Pérez de la Hoz R, Vetulli H, De All J, et al. Results of a Prospective Registry of Patients with Hypertensive Disorders of Pregnancy in a Center of the City of Buenos Aires. Rev Argent Cardiol 2022;90:124-9. http://dx.doi.org/10.7775/rac.v90.i2.20505
- 14 June 2023
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
Open AccessResultados de un registro prospectivo de pacientes con desórdenes hipertensivos del embarazo en un centro de la Ciudad de Buenos Aires
Background: Hypertensive disorders of pregnancy (HDP) complicate 10% of pregnancies. They are the main cause of maternal mortality and require a multidisciplinary team to address them.Objectives: The aim of this study was to quantify the prevalence and define the characteristics and outcome of HDP in a center with a program focused on its management.Methods: This was a continuous and prospective registry from November 2019 to July 2021 that included all patients with HDP [chronic hypertension (CHT), gestational hypertension (GHT), early-onset preeclampsia (EPE), late preeclampsia (LPE),superimposed preeclampsia (SIPE) and eclampsia] who met the inclusion criteria. Patients without medical coverage that prevented long-term outpatient follow-up at the institution were excluded. Baseline characteristics and evolution, treatment and persistent HT after puerperium were evaluated. The incidence of intrauterine growth retardation (IUGR), pretermdelivery, maternal mortality and neonatal death within the first 28 days of life was analyzed.Results: Among a total f 5825 deliveries/caesarean sections, 152 patients with GHT (37.5%), EPE (19.7%), LPE (38.8%), SIPE (3.3%), and eclampsia (0.6%) who met the inclusion criteria were included in the study. Mean age was 36.4±5.6 years. Aspirin was administered to 38.1% of patients. The most commonly used antihypertensive drugs were labetalol (65.8%) andenalapril (44.1%) during pregnancy and puerperium, respectively. There was no maternal mortality, and neonatal mortality was 3.6%. Persistent HT was 20.0%.Conclusion: Late preeclampsia was the most frequent HDP in the population analyzed. More than half of the patients who developed HDP did not receive preventive treatment with aspirin, showing a deficit in the identification of the population at risk. One in 5 HDP patients remained with CHTN after puerperium. How to cite this article: Correa Sadouet C, Rodríguez Granillo AM, Jensen H, Pérez de la Hoz R, Vetulli H, De All J, et al. Results of a Prospective Registry of Patients with Hypertensive Disorders of Pregnancy in a Center of the City of Buenos Aires. Rev Argent Cardiol 2022;90:124-9. http://dx.doi.org/10.7775/rac.v90.i2.20505
- 24 April 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (8) , 1000
Risk of Selection Bias in Observational Comparative Research on Left Main Revascularization Strategies
- 24 April 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (8) , 1000
Risk of Selection Bias in Observational Comparative Research on Left Main Revascularization Strategies
- Open Access
- 2 April 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (7) , 1321
High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized Data
Despite the introduction of drug-eluting stents (DES) significantly improved the efficacy and safety of percutaneous coronary interventions (PCI), particularly in a high-risk group of patients, the gap between PCI with his competitor’s coronary artery bypass surgery (CABG) and/or optimal medical treatment alone was not reduced. In this revision, we highlighted the fact that in recent years landmark randomized studies reported at mid and long-term follow-ups a high incidence of non-cardiac death, cancer incidence, or both in the DES group of patients. The overall incidence of non-cardiac death was significantly higher in the DES vs. the comparator arm: 5.5% and 3.8%, respectively, p = 0.000018, and non-cardiac death appears to be more divergent between DES vs. the comparator at the extended follow-up to expenses of the last one. One of these trials reported five times greater cancer incidence in the DES arm at late follow-up, 5% vs. 0.7% p < 0.0018. We review the potential reason for these unexpected findings, although we can discard that DES biology could be involved in it. Until all these issues are resolved, we propose that DES implantation should be tailored accorded patient age, life expectancy, and lesion complexity.
- 2 April 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (7) , 1321
Open AccessHigh Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized Data
Despite the introduction of drug-eluting stents (DES) significantly improved the efficacy and safety of percutaneous coronary interventions (PCI), particularly in a high-risk group of patients, the gap between PCI with his competitor’s coronary artery bypass surgery (CABG) and/or optimal medical treatment alone was not reduced. In this revision, we highlighted the fact that in recent years landmark randomized studies reported at mid and long-term follow-ups a high incidence of non-cardiac death, cancer incidence, or both in the DES group of patients. The overall incidence of non-cardiac death was significantly higher in the DES vs. the comparator arm: 5.5% and 3.8%, respectively, p = 0.000018, and non-cardiac death appears to be more divergent between DES vs. the comparator at the extended follow-up to expenses of the last one. One of these trials reported five times greater cancer incidence in the DES arm at late follow-up, 5% vs. 0.7% p < 0.0018. We review the potential reason for these unexpected findings, although we can discard that DES biology could be involved in it. Until all these issues are resolved, we propose that DES implantation should be tailored accorded patient age, life expectancy, and lesion complexity.
- 17 April 2022
- Published by Revista Argentina de Cardiologia
- Vol. 90 (2) , 124-129
Results of a Prospective Registry of Patients with Hypertensive Disorders of Pregnancy in a Center of the City of Buenos Aires
Background: Hypertensive disorders of pregnancy (HDP) complicate 10% of pregnancies. They are the main cause of maternal mortality and require a multidisciplinary team to address them. Objectives: The aim of this study was to quantify the prevalence and define the characteristics and outcome of HDP in a center with a program focused on its management. Methods: This was a continuous and prospective registry from November 2019 to July 2021 that included all patients with HDP [chronic hypertension (CHT), gestational hypertension (GHT), early-onset preeclampsia (EPE), late preeclampsia (LPE), superimposed preeclampsia (SIPE) and eclampsia] who met the inclusion criteria. Patients without medical coverage that prevented longterm outpatient follow-up at the institution were excluded. Baseline characteristics and evolution, treatment and persistent HTafter puerperium were evaluated. The incidence of intrauterine growth retardation (IUGR), preterm delivery, maternal mortality and neonatal death within the first 28 days of life was analyzed. Results: Among a total of 5825 deliveries/caesarean sections, 152 patients with GHT (37.5%), EPE (19.7%), LPE (38.8%), SIPE (3.3%), and eclampsia (0.6%) who met the inclusion criteria were included in the study. Mean age was 36.4±5.6 years. Aspirin was administered to 38.1% of patients. The most commonly used antihypertensive drugs were labetalol (65.8%) and enalapril (44.1%) during pregnancy and puerperium, respectively. There was no maternal mortality, and neonatal mortality was 3.6%. Persistent HT was 20.0%. Conclusion: Late preeclampsia was the most frequent HDP in the population analyzed. More than half of the patients who developed HDP did not receive preventive treatment with aspirin, showing a deficit in the identification of the population at risk. One in 5 HDP patients remained with CHT after puerperium.
- 17 April 2022
- Published by Revista Argentina de Cardiologia
- Vol. 90 (2) , 124-129
Results of a Prospective Registry of Patients with Hypertensive Disorders of Pregnancy in a Center of the City of Buenos Aires
Background: Hypertensive disorders of pregnancy (HDP) complicate 10% of pregnancies. They are the main cause of maternal mortality and require a multidisciplinary team to address them. Objectives: The aim of this study was to quantify the prevalence and define the characteristics and outcome of HDP in a center with a program focused on its management. Methods: This was a continuous and prospective registry from November 2019 to July 2021 that included all patients with HDP [chronic hypertension (CHT), gestational hypertension (GHT), early-onset preeclampsia (EPE), late preeclampsia (LPE), superimposed preeclampsia (SIPE) and eclampsia] who met the inclusion criteria. Patients without medical coverage that prevented longterm outpatient follow-up at the institution were excluded. Baseline characteristics and evolution, treatment and persistent HTafter puerperium were evaluated. The incidence of intrauterine growth retardation (IUGR), preterm delivery, maternal mortality and neonatal death within the first 28 days of life was analyzed. Results: Among a total of 5825 deliveries/caesarean sections, 152 patients with GHT (37.5%), EPE (19.7%), LPE (38.8%), SIPE (3.3%), and eclampsia (0.6%) who met the inclusion criteria were included in the study. Mean age was 36.4±5.6 years. Aspirin was administered to 38.1% of patients. The most commonly used antihypertensive drugs were labetalol (65.8%) and enalapril (44.1%) during pregnancy and puerperium, respectively. There was no maternal mortality, and neonatal mortality was 3.6%. Persistent HT was 20.0%. Conclusion: Late preeclampsia was the most frequent HDP in the population analyzed. More than half of the patients who developed HDP did not receive preventive treatment with aspirin, showing a deficit in the identification of the population at risk. One in 5 HDP patients remained with CHT after puerperium.